Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emergings in Brief (12/01)

This article was originally published in Start Up

Executive Summary

Start-Up showcases the following recently launched companies: ev3 Inc., Fossa Industries Inc., Plexus Vaccine Inc., Proteomic Research Services Inc. and VizX Labs LLC.

11400 73rd Avenue, Suite 134
Maple Grove, MN 55369
  • Phone: (763) 488-9762
  • Fax: (763) 488-9760
  • Web Site: www.ev3.com
  • Management: Paul Buckman, Pres., CEO; Dale Spencer, Chmn.; Jim Corbett, Pres., ev3 International; Stacy Enxing Seng, VP, Sales & Mktg.; Jerry Johnson, CFO
  • Company Founded: April 2001
  • Financing to Date: $10 million
  • Investors: Warburg Pincus; Vertical Group
  • Employees: 25
  • Industry Segment: Supplies, Equipment and Devices
  • Business: Endovascular devices for interventional cardiology, radiology, and neuroradiology.

Fossa Industries Inc.

580 Harrison Avenue, 4th Floor
Boston, MA 02118
  • Phone: (617) 275-7480
  • Web Site: www.fossaind.com
  • Management: Gloria Ro Kolb, Co-founder, Pres.; Mark Manasas, VP, Engineering; Michael Mitchell, MD, Co-founder; Nimish Parikh, Dir. of Bus. Dev.
  • Company Founded: 2001
  • Financing to Date: $100,000
  • Investors: Slater Center for Design Innovation
  • Employees: 3
  • Industry Segment: Supplies, Equipment and Devices
  • Business: Fossa Stone Sweeper designed to dilate the ureter and directly remove small or fragmented kidney stones.

Plexus Vaccine Inc.

11770 Bernardo Plaza Court, #370B
San Diego, CA 92128
  • Phone: (858) 385-9084
  • Fax: (858) 385-9087
  • Web Site: www.plexvax.com
  • Management: Susan K. Burgess, PhD, Pres.; Robert J. Deans, PhD, VP, R&D
  • Company Founded: April 2001
  • Financing to Date: $750,000
  • Investors: MolSoft LLC ; Rockport Venture Partners; private investors
  • Employees: 5
  • Partners/Alliances: MolSoft LLC; Quest Diagnostics; Structural Bioinformatics Inc.
  • Industry Segment: Bioinformatics; Vaccines
  • Business: Will combine structure-based drug design with genomic bioinformatics analysis of pathogens and their host species to design epitope-specific vaccines for human and veterinary diseases.

Proteomic Research Services Inc.

4401 Varsity Drive, Suite E
Ann Arbor, MI 48108
  • Phone: (734) 973-7914
  • Fax: (734) 973-7932
  • Web Site: www.proteomicresearchservices.com
  • Management: Mike Pisano, PhD, Co-founder; Beth Allen, PhD, Co-founder; Rick Edmondson, PhD, Co-founder
  • Company Founded: October 2001
  • Investors: Internal
  • Employees: 7
  • Industry Segment: Proteomics
  • Business: Spun off from Genomic Solutions Inc. to provide proteomics laboratory and consulting services to biotech and pharmaceutical companies, academic institutes, and government agencies.

VizX Labs LLC

2815 Eastlake Avenue East, Suite 300
Seattle, WA 98102
  • Phone: (206) 336-5606
  • Fax: (206) 336-5547
  • Web Site: www.vizxlabs.com
  • Management: J. Thomas Ranken, Co-founder and CEO; Bob Cottingham, Co-founder and CTO
  • Company Founded: January 2001
  • Financing to Date: $400,000
  • Investors: Private
  • Employees: 7
  • Industry Segment: Bioinformatics; Drug Discovery Tools
  • Business: Affordable, standardized, user-friendly desktop gene chip software. Aims to make bioinformatics software available to all levels of biological researchers, not just those in institutions that can afford enterprise-wide solutions.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel